Stick With Intravenous or Give Subcutaneous a Shot? Time and Other Considerations When Evaluating Cancer Drug Formulations.

Gupta, Arjun; Tregear, Michelle; Pace, Makala B; Vogel, Rachel I

Gupta, Arjun; Tregear, Michelle; Pace, Makala B; Vogel, Rachel I.

Afiliación

Gupta A; Divsion of Hematology, Oncology & Transplantation, University of Minnesota, Minneapolis, MN.
Tregear M; National Breast Cancer Coalition, Washington, DC.
Pace MB; Pharmacy Services, Huntsman Cancer Institute, University of Utah Health, Salt Lake City, UT.
Vogel RI; Department of Obstetrics, Gynecology, and Women's Health, University of Minnesota, Minneapolis, MN.

JCO Oncol Pract ; : OP2400501, 2024 Aug 02.

Article en En | MEDLINE | ID: mdl-39094070

ABSTRACT

ABSTRACT

Time and other considerations when evaluating a switch to newer drug formulations (eg, subQ vs IV).

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: JCO Oncol Pract Año: 2024 Tipo del documento: Article